Browsing: Lung

Just when you thought there was nothing else to possibly glean from RTOG 0617, this study combined trial data with…

In this phase 1 study, 45 patients with stage IV NSCLC and symptomatic central primary tumors were treated with a…

Top Line: Does adjuvant selpercatinib improve outcomes for early stage, RET fusion positive NSCLC?The Study: RET (REarranged during Transfection) encodes…

A thought-provoking dosimetric analysis of 50 lung SBRT plans indicates optimizing median dose to the 4D-tumor (ITV) best translates to…

Top Line: Is dual immune checkpoint inhibition better than durvalumab after chemoradiation for stage III NSCLC?The Study: Chemoradiation followed by…

Top Line: It’s hard to imagine much improving the safety and local control of ablative lung radiation for early-stage lung…

Here’s a multidisciplinary international expert consensus on thoracic reirradiation. In it you’ll find recommendations on careful patient selection with biopsy…

Top Line: Should NSCLC patients who aren’t candidates for concurrent chemoradiation receive immunotherapy and radiation?The Study: The standard treatment for…

Top Line: Does thoracic radiation improve survival in the context of immunotherapy for extensive stage small cell lung cancer?The Study:…

The human microbiome can play an important, thought not fully understood, role in immune modulation and response to immunotherapy. This…